UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
October 2, 2024 4:15 P.M.
Form:
S-3
CIK:
0001636282
Company Name:
Spyre Therapeutics, Inc.
File Number:
333-282252